---
title: "C9-ALS/FTD"
subtitle: IMED 7170

format:
  revealjs:
    theme: serif
    # incremental: true
    footnotes-hover: true
    slide-number: true
    scrollable: true
    progress: true
    embed-resources: true
    # chalkboard: true
    css: oct_jc.css

revealjs-plugins:
  - pointer

author:
  - name: Andy Van Domelen
    email: vandomea@myumanitoba.ca
---




## Overview


:::: {.columns}
::: {.column width=60%}

:::{.fragment .fade-in-then-semi-out fragment-index=1}
**ALS-FTD**
:::

:::{.fragment .fade-in fragment-index=2 style="font-size: 40pt;"}
**C9orf72**
:::

:::{.fragment .fade-in-then-semi-out fragment-index=3}
Healthy function
:::

:::{.fragment .fade-in-then-semi-out fragment-index=4}
Hexanucleotide Repeat Expansion (HRE)
:::

:::{.fragment .fade-in-then-semi-out fragment-index=5}
Pathogenic Mechanisms
:::

:::{.fragment .fade-in-then-semi-out fragment-index=6}
**Treatments**
:::

:::{.fragment .fade-in-then-semi-out fragment-index=7}
**In the Clinic**
:::

:::{.fragment .fade-in fragment-index=8}
**Future Directions**
:::
  
:::
::::


:::{.fragment .fade-in-then-out fragment-index=1}
::: {.button-container style="position:absolute; top: 50px; left: 450px; width: 600px; height: auto;"}
[![](img/ALS_system.png)](https://www.nature.com/articles/nrdp201771){target="_blank"}
:::
:::

:::{.fragment .fade-in-then-out fragment-index=2}
::: {.button-container style="position:absolute; top: 200px; left: 250px; width: 800px; height: auto;"}
[![](img/chr_9.png)](https://commons.wikimedia.org/w/index.php?curid=61368792){target="_blank"}
:::
:::

:::{.fragment .fade-in-then-out fragment-index=3}
::: {.button-container style="position:absolute; top: 200px; left: 350px; width: 750px; height: auto;"}
[![](img/autophagy.webp)](https://blog.cellsignal.com/autophagy-its-a-cell-eat-cell-world){target="_blank"}
:::
:::

:::{.fragment .fade-in-then-out fragment-index=4}
::: {.button-container style="position:absolute; top: 375px; left: 350px; width: 650px; height: auto;"}
[![](img/C9_repeats.png)](https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(14)70233-9/abstract){target="_blank"}
:::
:::

:::{.fragment .fade-in-then-out fragment-index=5}
::: {.button-container style="position:absolute; top: 375px; left: 455px; width: 600px; height: auto;"}
[![](img/C9_path.png)](https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2020.00684/full){target="_blank"}
:::
:::

:::{.fragment .fade-in-then-out fragment-index=6}
::: {.button-container style="position:absolute; top: 475px; left: 380px; width: 650px; height: auto;"}
[![](img/ASO_quick.png)](https://www.nature.com/articles/nrneurol.2017.148){target="_blank"}
:::
:::

## ALS and FTD
### Amyotrophic Lateral Sclerosis {style="color: gray; font-size: 25pt;"}

:::: {.columns}
::: {.column width=60%}

:::{.fragment .fade-in-then-semi-out fragment-index=1 }
Complex disease of motor neurons
:::

:::{.fragment .fade-in-then-semi-out fragment-index=2}
[Muscle *and* cognitive impairment]{.smaller-text}
:::

:::{.fragment .fade-in-then-semi-out fragment-index=3}
Familial and sporadic
:::

:::{.fragment .fade-in-then-semi-out fragment-index=4}
[Numerous molecular factors influence expression]{.smaller-text}
:::

:::
::::

:::{.fragment .fade-in-then-out fragment-index=1 style="position:absolute; top: 215px; left: 200px; width: 700px; height: auto;"}
![](img/ALS/ALS_MN.webp)
[Mead 2022](https://www.nature.com/articles/s41573-022-00612-2){.img-link}
:::

:::{.fragment .fade-in-then-out fragment-index=2 style="position:absolute; top: 50px; left: 550px; width: 450px; height: auto;"}
![](img/ALS/ALS_body.png)
[wiki](https://en.wikipedia.org/wiki/ALS){.img-link}
:::

:::{.fragment .fade-in-then-out fragment-index=3 style="position:absolute; top: 50px; left: 550px; width: 450px; height: auto;"}
![](img/ALS/fALS_sALS.png)
[Renton 2013](https://www.nature.com/articles/nn.3584){.img-link}
:::

:::{.fragment .fade-in-then-out fragment-index=4 style="position:absolute; top: 25px; left: 625px; width: 400px; height: auto;"}
![](img/ALS_system.png)
[Hardiman 2017](https://www.nature.com/articles/nrdp201771){.img-link}
:::


## ALS and FTD
### Frontotemporal Dementia {style="color: gray; font-size: 25pt;"}

:::: {.columns}
::: {.column width=50%}

:::{.fragment .fade-in-then-semi-out fragment-index=1}
[Second most common form of pre-senile dementia]{.smaller-text}
:::

:::{.fragment .fade-in-then-semi-out fragment-index=2}
[Frontal lobe degeneration and behavioral abnormalities]{.smaller-text}
:::

:::{.fragment .fade-in-then-semi-out fragment-index=3}
Familial and sporadic
:::

:::{.fragment .fade-in-then-semi-out fragment-index=4}
[Numerous molecular factors influence expression]{.smaller-text}
:::

:::
::::


:::{.fragment .fade-in-then-out fragment-index=1 style="position:absolute; top: 150px; left: 500px; width: 450px; height: auto;"}
![](img/FTD/FTD_chart.jpg)
[QBI](https://qbi.uq.edu.au/brain/dementia/types-dementia){.img-link}
:::

:::{.fragment .fade-in-then-out fragment-index=2 style="position:absolute; top: 25px; left: 550px; width: 360px; height: auto;"}
![](img/FTD/frontal_lobe_ftd.jpg)
[Cleveland Clinic](https://my.clevelandclinic.org/health/diseases/21075-frontotemporal-dementia){.img-link}
:::

:::{.fragment .fade-in fragment-index=3 style="position:absolute; top: 50px; left: 550px; width: 450px; height: auto;"}
![](img/FTD/f_s_ftd.webp)
[AFTD](https://www.theaftd.org/what-is-ftd/genetics-overview/){.img-link}
:::



## ALS and FTD
### ALS/FTD {style="color: gray; font-size: 25pt;"}

:::: {.columns}
::: {.column width=50%}

:::{.fragment .fade-in-then-semi-out fragment-index=1}
[Considerable clinical overlap]{.smaller-text}
:::

:::{.fragment .fade-in-then-semi-out fragment-index=2}
[Shared Molecular Signatures / biomarkers]{.smaller-text}
:::

:::{.fragment .fade-in-then fragment-index=3}
["Spectrum"]{style="color: #cc4631;"}
:::

:::
::::


:::{.fragment .fade-in fragment-index=2 style="position:absolute; top: 275px; left: 300px; width: 700px; height: auto;"}
![](img/spectrum.jpg)
[Lee 2017](https://www.sciencedirect.com/science/article/pii/S0006899315007404){.img-link}
:::



## ALS and FTD
### C9-related ALS/FTD {style="color: gray; font-size: 25pt;"}

:::: {.columns}
::: {.column width=50%}

:::{.fragment .fade-in-then-semi-out fragment-index=1}
Why C9orf72?
:::

:::{.nonincremental .fragment .fade-in fragment-index=3}
-   Healthy C9orf72
-   HRE mutation
-   Pathology
:::

:::
::::

:::{.fragment .fade-in fragment-index=2 style="position:absolute; top: 75px; left: 375px; width: 700px; height: auto;"}
![](img/c9/c9_als_ftd_processes.webp)
[Balendra 2018](https://www.nature.com/articles/s41582-018-0047-2){.img-link}
:::



## C9orf72
### Healthy C9orf72 {style="color: gray; font-size: 25pt;"}

    
:::{.fragment .fade-in-then-semi-out fragment-index=1}
Gene Structure
:::

:::{.fragment .fade-in-then-semi-out fragment-index=2}
Isoforms
:::

:::{.fragment .fade-in-then-semi-out fragment-index=3}
Normal Gene Function
:::

:::{.fragment .fade-in-then-semi-out fragment-index=4}
Distribution in the body
:::


:::{.fragment .fade-in fragment-index=1 style="position:absolute; top: 75px; left: 450px; width: 500px; height: auto;"}
::: {.fragment .fade-out fragment-index=3}
![](img/c9/healthy_c9.png)
[Smeyers 2021](https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2021.661447/full){.img-link}
:::
:::

:::{.fragment .fade-in fragment-index=3 style="position:absolute; top: 75px; left: 450px; width: 600px; height: auto;"}
![](img/c9/c9_func.webp)
[Braems 2020](https://link.springer.com/article/10.1007/s00401-020-02214-x){.img-link}
:::



## C9orf72
### Hexanucleotide Repeat Expansion (HRE) {style="color: gray; font-size: 25pt;"}

:::: {.columns}
::: {.column width=40%}
:::{.fragment .fade-in-then-semi-out fragment-index=1}
Structure
:::

:::{.fragment .fade-in-then-semi-out fragment-index=2}
Variable Repeat Numbers
:::

:::{.fragment .fade-in-then-semi-out fragment-index=3}
Incomplete Penetrance
:::

:::{.fragment .fade-in-then-semi-out fragment-index=4}
[Variable Expressivity]{.smaller-text}
:::

:::{.fragment .fade-in-then-semi-out fragment-index=5}
Somatic Instability
:::

:::{.fragment .fade-in-then-semi-out fragment-index=6}
Repeat Contraction
:::
:::
::::

:::{.fragment .fade-in-then-semi-out fragment-index=1 style="position:absolute; top: 120px; left: 350px; width: 600px; height: auto;"}
![](img/hre/C9_path_repeats.png)
[Smeyers 2021](https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2021.661447/full){.img-link}
:::

:::{.fragment .fade-in fragment-index=2 style="position:absolute; top: 350px; left: 375px; width: 675px; height: auto;"}
![](img/C9_repeats.png)
[Rohrer 2015](https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(14)70233-9/fulltext){.img-link}
:::


## C9orf72 Pathogenic Mechanisms

:::{style="position:absolute; top: 200px; left: 100px; width: 850px; height: auto;"}
![](img/C9_path.png)
[Ranganathan 2020](https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2020.00684/full){.img-link}
:::


## C9orf72 Pathogenic Mechanisms
### Haploinsufficiency {style="color: gray; font-size: 25pt;"}

:::: {.columns}
::: {.column width=40%}
:::{.fragment .fade-in-then-semi-out fragment-index=1}
Hypermethylation
:::

:::{.fragment .fade-in-then-semi-out fragment-index=2}
Dysregulated C9orf72 function
:::

:::{.fragment .fade-in-then-semi-out fragment-index=3}
Immune phenotypes
:::

:::{.fragment .fade-in-then-semi-out fragment-index=4}
Additive Effects
:::

:::
::::

:::{.fragment .fade-in-then-out fragment-index=1 style="position:absolute; top: 75px; left: 450px; width: 400px; height: auto;"}
![](img/haplo/C9_LOF.png)
[Braems 2020](https://link.springer.com/article/10.1007/s00401-020-02214-x){.img-link}
:::

:::{.fragment .fade-in-then-out fragment-index=2 style="position:absolute; top: 75px; left: 450px; width: 600px; height: auto;"}
![](img/c9/c9_func.webp)
[Braems 2020](https://link.springer.com/article/10.1007/s00401-020-02214-x){.img-link}
:::

:::{.fragment .fade-in-then-out fragment-index=3 style="position:absolute; top: 75px; left: 450px; width: 550px; height: auto;"}
![](img/haplo/microglia.webp)
[Rana Abdelhalim](https://www.ataxia.org/scasourceposts/snapshot-what-are-microglia/){.img-link}
:::

:::{.fragment .fade-in-then-out fragment-index=4 style="position:absolute; top: 200px; left: 450px; width: 600px; height: auto;"}
![](img/haplo/additive.png)
[Braems 2020](https://link.springer.com/article/10.1007/s00401-020-02214-x){.img-link}
:::

## C9orf72 Pathogenic Mechanisms
### RNA Foci {style="color: gray; font-size: 25pt;"}

:::: {.columns}
::: {.column width=40%}
:::{.fragment .fade-in-then-semi-out fragment-index=1}
G-quadruplex structure
:::

:::{.fragment .fade-in-then-semi-out fragment-index=2}
Sequester RNA-binding proteins
:::

:::{.fragment .fade-in-then-semi-out fragment-index=3}
Frontal Cortex (FTD) and Spinal Cord (ALS)
:::


:::
::::


```{=html}
<style>
iframe#app-8C7B {
  width: 400px;
  height: 500px;
  position: absolute;
  left: 450px;
  top: 100px;
}
</style>
```

::: {.fragment .fade-in-then-out fragment-index=1}
{{< mol-rcsb 8C7B >}}
:::

:::{.fragment .fade-in-then-out fragment-index=2 style="position:absolute; top: 75px; left: 450px; width: 500px; height: auto;"}
![](img/foci/c9_rbp.jpg)
[Fay 2017](https://www.sciencedirect.com/science/article/pii/S2211124717317606){.img-link}
:::

:::{.fragment .fade-in fragment-index=3 style="position:absolute; top: 75px; left: 450px; width: 450px; height: auto;"}
![](img/foci/spinal_cord.png)
[wiki](https://commons.wikimedia.org/wiki/File:UMN_vs_LMN.png){.img-link}
:::




## C9orf72 Pathogenic Mechanisms
### Dipeptide Repeat (DPR) Proteins {style="color: gray; font-size: 25pt;"}

:::: {.columns}
::: {.column width=40%}

:::{.fragment .fade-in-then-semi-out fragment-index=1}
Repeat-associated non-ATG (RAN) translation
:::

:::{.fragment .fade-in fragment-index=2}
Different DPRs = Different mechanisms
:::

:::
::::

:::{.fragment .fade-in-then-out fragment-index=1 style="position:absolute; top: 150px; left: 450px; width: 550px; height: auto;"}
![](img/DPR/RAN.jpg)
[Cleary 2018](https://www.jbc.org/article/S0021-9258(20)35084-5/fulltext){.img-link}
:::

:::{.fragment .fade-in-then-out fragment-index=2 style="position:absolute; top: 125px; left: 450px; width: 600px; height: auto;"}
![](img/DPR/DPR_reading_frame.jpg)
[Isaacs Lab](https://adrianisaacslab.com/research/){.img-link}
:::

:::{.fragment .fade-in fragment-index=3 style="position:absolute; top: 125px; left: 450px; width: 600px; height: auto;"}
![](img/DPR/DPR_effect.png)
[Masrori 2022](https://molecularneurodegeneration.biomedcentral.com/articles/10.1186/s13024-022-00525-z){.img-link}
:::



## C9-ALS/FTD
### Treatment {style="color: gray; font-size: 25pt;"}

:::: {.columns}
::: {.column width=40%}

:::{.fragment .fade-in-then-semi-out fragment-index=1}
Antisense oligonucleotides (ASOs)
:::

:::{.fragment .fade-in-then-semi-out fragment-index=2}
Small Molecule
:::

:::{.fragment .fade-in-then-semi-out fragment-index=3}
Gene Therapy?
:::


:::
::::

:::{.fragment .fade-in-then-out fragment-index=1 style="position:absolute; top: 75px; left: 400px; width: 475px; height: auto;"}
![](img/treatment/aso.png)
[Rinaldi 2017](https://www.nature.com/articles/nrneurol.2017.148){.img-link}
:::

:::{.fragment .fade-in-then-semi-out fragment-index=2 style="position:absolute; top: 150px; left: 400px; width: 600px; height: auto;"}
![](img/treatment/RNA_RBP.webp)
[Hentze 2018](https://www.nature.com/articles/nrm.2017.130){.img-link}
:::

<!-- :::{.fragment .fade-in fragment-index=3 style="position:absolute; top: 75px; left: 450px; width: 400px; height: auto;"} -->
<!-- ![](img/treatment/casrx.png) -->
<!-- [Guo 2022](https://www.cell.com/molecular-therapy-family/nucleic-acids/fulltext/S2162-2531%2822%2900090-7){.img-link} -->
<!-- ::: -->

## C9-ALS/FTD
### In the clinic {style="color: gray; font-size: 25pt;"}

:::: {.columns}
::: {.column width=40%}

:::{.fragment .fade-in-then-semi-out fragment-index=1}
Diagnosis
:::

:::{.fragment .fade-in-then-semi-out fragment-index=2}
Prognosis
:::

:::{.fragment .fade-in-then-semi-out fragment-index=3}
Issues
:::

:::
::::

:::{.fragment .fade-in-then-out fragment-index=1 style="position:absolute; top: 150px; left: 450px; width: 475px; height: auto; background-color: rgba(200, 204, 200, 0.7);"}
-   Muscle Biopsy
-   Cognitive Tests
-   MRI
-   Fluid Tests
-   Family History
:::

:::{.fragment .fade-in-then-out fragment-index=2 style="position:absolute; top: 150px; left: 450px; width: 475px; height: auto; background-color: rgba(200, 204, 200, 0.7);"}
-   ALS: 20-48 months
-   FTD: 3-14 years
-   ALS/FTD: ~2.5 years
:::

:::{.fragment .fade-in-then-out fragment-index=3 style="position:absolute; top: 150px; left: 450px; width: 475px; height: auto; background-color: rgba(200, 204, 200, 0.7);"}
-   Disease mimics
-   Prolonged diagnosis time
-   False positives & false negatives
:::

## C9-ALS/FTD
### Unknowns {style="color: gray; font-size: 25pt;"}

:::: {.columns}
::: {.column width=40%}

:::{.fragment .fade-in-then-semi-out fragment-index=1}
[Contribution of molecular mechanisms]{.smaller-text}
:::

:::{.fragment .fade-in-then-semi-out fragment-index=2}
Complex "interactome"
:::

:::{.fragment .fade-in fragment-index=3}
Familial vs. sporadic
:::

:::
::::

:::{.fragment .fade-in-then-out fragment-index=1 style="position:absolute; top: 200px; left: 250px; width: 700px; height: auto;"}
![](img/ALS/ALS_MN.webp)
[Mead 2022](https://www.nature.com/articles/s41573-022-00612-2){.img-link}
:::

:::{.fragment .fade-in-then-out fragment-index=2 style="position:absolute; top: 200px; left: 350px; width: 600px; height: auto;"}
![](img/gene-environment.png)
[Uwaezuoke 2016](https://www.spandidos-publications.com/10.3892/br.2016.781){.img-link}
:::

:::{.fragment .fade-in-then-out fragment-index=3 style="position:absolute; top: 75px; left: 475px; width: 425px; height: auto;"}
![](img/ALS/fALS_sALS.png)
[Renton 2013](https://www.nature.com/articles/nn.3584){.img-link}
:::

# Thank you!

::: {.footer}
[LinkedIn](https://www.linkedin.com/in/andy-vandomelen/)
:::

#


## C9orf72 Pathogenic Mechanisms
### Other Molecules {style="color: gray; font-size: 25pt;"}

:::: {.columns}
::: {.column width=40%}

:::{.fragment .fade-in-then-semi-out fragment-index=1}
TDP-43
:::

:::{.fragment .fade-in-then-semi-out fragment-index=2}
p62
:::

:::{.fragment .fade-in-then-semi-out fragment-index=3}
TBK1
:::

:::
::::

:::{.fragment .fade-in-then-out fragment-index=1 style="position:absolute; top: 75px; left: 400px; width: 650px; height: auto;"}
![](img/other/TDP_43_func.jpg)

[de Mena 2021](https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2021.772226/full){.img-link}
:::

:::{.fragment .fade-in-then-out fragment-index=2 style="position:absolute; top: 75px; left: 400px; width: 600px; height: auto;"}
![](img/other/p62.jpg)
[Zaffagnini 2018](https://www.tandfonline.com/doi/full/10.1080/15548627.2018.1462079){.img-link}
:::

:::{.fragment .fade-in fragment-index=3 style="position:absolute; top: 125px; left: 250px; width: 800px; height: auto;"}
![](img/other/c9_p62_tbk1.jpg)
[Corbier 2016](https://www.tandfonline.com/doi/full/10.1080/21541248.2016.1212688#abstract){.img-link}
:::
